What happened
Telcon RF Pharmaceutical updated a previously disclosed supply contract with Emmaus Life Sciences.Inc., now worth US$35.9M, about 181.15% of its recent annual revenue, running through Jul 2027.
For context, this single contract equals about 181.15% of the company's most recent annual revenue.
| Counterparty | Emmaus Life Sciences.Inc. |
|---|---|
| Contract value | US$35.9M |
| vs. recent revenue | 181.15% |
| Through | Jul 2027 (from Jul 2017) |
| Filed | 2026-07-10, [Amended] Supply contract signed |
| Source | DART rcept 20260710900713 → open original filing |
Source: DART. Information only, not investment advice.